Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.74 |
| ▸ | HPGD | P15428 | 2/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.69 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.67 |
| ▸ | DRD2 | P14416 | 2/20 | 0.62 |
| ▸ | DRD3 | P35462 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25642094 | 0.87 | HRH4 (0.65) | ALDH1A1HPGDL3MBTL1POLBMAPT | |
| SCHEMBL15170873 | 0.86 | ALDH1A1 (1.00) | ALDH1A1HPGDL3MBTL1POLBMAPT | |
| SCHEMBL19864572 | 0.86 | ALDH1A1 (1.00) | ALDH1A1HPGDL3MBTL1POLBMAPT | |
| SCHEMBL16598855 | 0.84 | GRIN2B (0.71) | ALDH1A1HPGDL3MBTL1POLBMAPT | |
| SCHEMBL12918736 | 0.82 | DRD2 (0.61) | ALDH1A1HPGDL3MBTL1MAPTGRIN2B | |
| Befuraline SCHEMBL499156 | 0.81 | GRIN2B (0.91) | ALDH1A1HPGDL3MBTL1POLBMAPT | |
| Befuraline SCHEMBL30036410 | 0.81 | GRIN2B (0.91) | ALDH1A1HPGDL3MBTL1POLBMAPT | |
| Befuraline SCHEMBL4320804 | 0.80 | GRIN2B (0.88) | ALDH1A1HPGDL3MBTL1POLBMAPT | |
| SCHEMBL14430741 | 0.80 | MMP13 (0.76) | DRD2DRD3HRH3 | |
| SCHEMBL15502198 | 0.79 | MMP13 (0.81) | DRD2DRD3HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110009420-A1 | Histamine H3 Receptor Ligands | HIGH POINT PHARMACEUTICALS, LLC (US) | 2011-01-13 | — | — | US | disclosed |
| US-20110009420-A1 | Histamine H3 Receptor Ligands | HIGH POINT PHARMACEUTICALS, LLC (US) | 2011-01-13 | — | — | US | disclosed |
| US-20110009420-A1 | Histamine H3 Receptor Ligands | HIGH POINT PHARMACEUTICALS, LLC (US) | 2011-01-13 | — | — | US | disclosed |
| WO-2009126782-A1 | HISTAMINE H3 RECEPTOR LIGANDS | HIGH POINT PHARMACEUTICALS, LLC (US) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009126782-A1 | HISTAMINE H3 RECEPTOR LIGANDS | HIGH POINT PHARMACEUTICALS, LLC (US) | 2009-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009420-A1 | Histamine H3 Receptor Ligands | HRH3, HRH4, HRH2 | ALDH1A1 1218/4885HPGD 806/4885L3MBTL1 2416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.